Impact of heart failure on the behavior of human neonatal stem cells in vitro
| dc.contributor.author | Klose, Kristin | |
| dc.contributor.author | Roy, Rajika | |
| dc.contributor.author | Brodarac, Andreja | |
| dc.contributor.author | Kurtz, Andreas | |
| dc.contributor.author | Ode, Andrea | |
| dc.contributor.author | Kang, Kyung-Sun | |
| dc.contributor.author | Bieback, Karen | |
| dc.contributor.author | Choi, Yeong-Hoon | |
| dc.contributor.author | Stamm, Christof | |
| dc.date.accessioned | 2023-09-01T17:04:58Z | |
| dc.date.available | 2023-09-01T17:04:58Z | |
| dc.date.issued | 2013-12 | |
| dc.date.updated | 2023-09-01T17:04:58Z | |
| dc.description.abstract | jats:titleAbstract</jats:title> jats:sec jats:titleBackground</jats:title> jats:pClinical cardiac cell therapy using autologous somatic stem cells is restricted by age and disease-associated impairment of stem cell function. Juvenile cells possibly represent a more potent alternative, but the impact of patient-related variables on such cell products is unknown. We therefore evaluated the behavior of neonatal cord blood mesenchymal stem cells (CB-MSC) in the presence of serum from patients with advanced heart failure (HF).</jats:p> </jats:sec> jats:sec jats:titleMethods</jats:title> jats:pHuman serum was obtained from patients with severe HF (n = 21) and from healthy volunteers (n = 12). To confirm the systemic quality of HF in the sera, TNF-α and IL-6 were quantified. CB-MSC from healthy neonates were cultivated for up to 14 days in medium supplemented with 10% protein-normalized human HF or control serum or fetal calf serum (FCS).</jats:p> </jats:sec> jats:sec jats:titleResults</jats:title> jats:pAll HF sera contained increased cytokine concentrations (IL-6, TNF-α). When exposed to HF serum, CB-MSC maintained basic MSC properties as confirmed by immunophenotyping and differentiation assays, but clonogenic cells were reduced in number and gave rise to substantially smaller colonies in the CFU-F assay. Cell cycle analysis pointed towards G1 arrest. CB-MSC metabolic activity and proliferation were significantly impaired for up to 3 days as measured by MTS turnover, BrdU incorporation and DAPI + nuclei counting. On day 5, however, CB-MSC growth kinetics approached control serum levels, though protein expression of cell cycle inhibitors (p21, p27), and apoptosis marker Caspase 3 remained elevated. Signal transduction included the stress and cytokine-induced JNK and ERK1/2 MAP kinase pathways.</jats:p> </jats:sec> jats:sec jats:titleConclusions</jats:title> jats:pHeart failure temporarily inhibits clonality and proliferation of “healthy” juvenile MSC jats:italicin vitro</jats:italic>. Further studies should address the jats:italicin vivo</jats:italic> and clinical relevance of this finding.</jats:p> </jats:sec> | |
| dc.identifier.issn | 1479-5876 | |
| dc.identifier.uri | ||
| dc.language | en | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Journal of Translational Medicine | |
| dc.relation.isversionof | 10.1186/1479-5876-11-236 | |
| dc.title | Impact of heart failure on the behavior of human neonatal stem cells in vitro | |
| dc.type | Journal article | |
| duke.contributor.orcid | Roy, Rajika|0000-0001-9394-3224 | |
| pubs.issue | 1 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Surgery | |
| pubs.organisational-group | Surgery, Cardiovascular and Thoracic Surgery | |
| pubs.publication-status | Published | |
| pubs.volume | 11 |
Files
Original bundle
- Name:
- Roy neonatal cells J Trans med.pdf
- Size:
- 1.91 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version